Literature DB >> 10722855

Sleep influences on homeostatic functions: implications for sudden infant death syndrome.

R M Harper1, H C Kinney, P J Fleming, B T Thach.   

Abstract

The mechanisms underlying the sudden infant death syndrome (SIDS) appear to have origins in the fetal environment resulting in neural damage which later compromises responses to breathing or blood pressure challenges during sleep. The deficits appear to involve alterations in neurotransmitter receptors within regions involved in chemoreception and cardiovascular control. SIDS risk is enhanced by pre- and postnatal nicotine exposure, and possibly by hypoxic experiences. The prone sleeping position plays a significant role in risk, as do head positions that minimize facial escape from enclosed spaces; elevated body temperature may also be a factor. Compensatory mechanisms, including diminished gasping ability, relative failure to arouse to a safer state, or a failure to recruit respiratory efforts to overcome a blood pressure loss have been the object of recent research efforts. The findings suggest that the fatal event involves a neurally-compromised infant, circumstances that challenge vital physiology, most likely during sleep, at a particular developmental period.

Entities:  

Mesh:

Year:  2000        PMID: 10722855     DOI: 10.1016/s0034-5687(99)00107-3

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  30 in total

1.  Mattresses, microenvironments, and multivariate analyses.

Authors:  Peter J Fleming; Peter S Blair; Ed A Mitchell
Journal:  BMJ       Date:  2002-11-02

2.  Comparison of evoked arousability in breast and formula fed infants.

Authors:  R S C Horne; P M Parslow; D Ferens; A-M Watts; T M Adamson
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

Review 3.  From hindbrain segmentation to breathing after birth: developmental patterning in rhombomeres 3 and 4.

Authors:  Fabrice Chatonnet; Eduardo Domínguez del Toro; Muriel Thoby-Brisson; Jean Champagnat; Gilles Fortin; Filippo M Rijli; Christelle Thaëron-Antôno
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

Review 4.  The cerebellum and respiratory control.

Authors:  R M Harper
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

5.  Is SIDS associated with sleep? : A report of six cases demonstrating difficulty in this determination.

Authors:  Henry F Krous; Amy E Chadwick; Christina Stanley; J Bruce Beckwith
Journal:  Forensic Sci Med Pathol       Date:  2005-09       Impact factor: 2.007

6.  Perinatal exposure to nicotine causes deficits associated with a loss of nicotinic receptor function.

Authors:  Gary Cohen; Jean-Christophe Roux; Régis Grailhe; Girvan Malcolm; Jean-Pierre Changeux; Hugo Lagercrantz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

7.  Reconfiguration of the pontomedullary respiratory network: a computational modeling study with coordinated in vivo experiments.

Authors:  I A Rybak; R O'Connor; A Ross; N A Shevtsova; S C Nuding; L S Segers; R Shannon; T E Dick; W L Dunin-Barkowski; J M Orem; I C Solomon; K F Morris; B G Lindsey
Journal:  J Neurophysiol       Date:  2008-07-23       Impact factor: 2.714

8.  Prone sleeping impairs circulatory control during sleep in healthy term infants: implications for SIDS.

Authors:  Stephanie R Yiallourou; Adrian M Walker; Rosemary S C Horne
Journal:  Sleep       Date:  2008-08       Impact factor: 5.849

9.  Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation.

Authors:  Xiuping Gao; Lei Zhao; Jianguo Zhuang; Na Zang; Fadi Xu
Journal:  FASEB J       Date:  2017-06-14       Impact factor: 5.191

10.  Prenatal alcohol exposure alters biobehavioral reactivity to pain in newborns.

Authors:  Tim F Oberlander; Sandra W Jacobson; Joanne Weinberg; Ruth E Grunau; Christopher D Molteno; Joseph L Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2010-01-27       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.